Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, July 22 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

Infectious Disease Testing Services

Active

State & Local

Response Deadline08/07/2026, 11:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Integral Care is seeking qualified providers to deliver diagnostic testing services for HIV, Hepatitis B and C, tuberculosis, sexually transmitted infections, and other communicable diseases specifically within behavioral health populations. The contract is structured as a subcontract with a response deadline of August 7, 2026, and is categorized under NAICS code 621511, indicating it pertains to medical and diagnostic laboratories. Testing must be conducted in a manner that accommodates the unique needs of individuals receiving behavioral health services, ensuring accessibility, confidentiality, and cultural competence. The scope includes sample collection, laboratory analysis, result reporting, and linkage to care, with performance expected to align with public health standards and best practices for high-risk and underserved communities. No set-aside provisions are indicated, and the place of performance and office address details are unspecified, suggesting services may be delivered across Texas through mobile units, clinics, or partnerships with behavioral health facilities. Interested parties must review the full solicitation via the provided Texas SmartBuy portal link.

General Info

Integral Care seeks providers for communicable disease testing in behavioral health populations through August 2026, Texas-wide.

Agency

Texas → INTEGRAL CARE

NAICS

621511 - Medical LaboratoriesView NAICS

Place of Performance

TX, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 17

subcontract

Response DeadlineAug 7

Submission deadline

Response Deadline

08/07/2026, 11:00:00 PM UTCin 18 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyTexas → INTEGRAL CARE

ContactsNo contacts available

OfficeN/A

Organization / Agency

Texas → INTEGRAL CARE

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Diagnostic testing for HIV, Hepatitis B/C, TB, STIs, and other communicable diseases in behavioral health populations.

Similar Contracts

Same NAICS industry code

RFP No. 26-2973-7JOK - Multi-Cancer Early Detection Testing ServicesHenrico County Government in Virginia is seeking qualified firms to provide multi-cancer early detection testing services under RFP No. 26-2973-7JOK, issued as solicitation number RFP-124678. The opportunity, posted on July 20, 2026, requires proposers to deliver testing services aligned with the detailed Scope of Services outlined in the solicitation, focusing on early detection capabilities for multiple types of cancer. Responses are due by August 4, 2026, at 4:00 PM Eastern Time, and the contract will be awarded based on the vendor’s ability to meet technical, operational, and compliance requirements specified in the RFP. The services are intended for performance within Henrico County, Virginia, and are managed by the county’s SLED-type organization, with Joseph Knott serving as the point of contact for inquiries, reachable via email at kno008@henrico.gov or phone at 804-501-5649. All proposals must be submitted through the designated vendor portal linked in the solicitation details.

Henrico County Government

POSTED

about 8 hours ago

DEADLINE

Toxicology and Drug Screening ServicesIntegral Care is seeking a subcontractor to provide comprehensive urine and blood toxicology testing services, including chain-of-custody procedures and STAT screening for substance use in crisis admission scenarios. The contract requires timely, accurate, and compliant laboratory analysis supporting behavioral health and emergency response efforts, with strict adherence to federal and state regulatory standards for sample handling and reporting. Services must be available to meet urgent clinical needs, ensuring rapid turnaround for critical patient care decisions. The opportunity is open to qualified vendors who can demonstrate experience in forensic and clinical toxicology, with the capacity to manage high-volume testing under time-sensitive conditions. Interested parties must submit responses by August 7, 2026, through the TX SmartBuy portal, and the work is expected to be performed in Texas under the oversight of Integral Care. The contract falls under NAICS code 621511, indicating it targets medical and diagnostic laboratories, and no set-aside provisions are specified, making it open to all eligible contractors.

POSTED

DEADLINE

Core Clinical Laboratory Testing ServicesIntegral Care is seeking a subcontractor to provide routine and specialized clinical laboratory testing services specifically for behavioral health patients, including complete blood counts, comprehensive metabolic panels, and lipid panels. The contract, titled Core Clinical Laboratory Testing Services, is posted under NAICS code 621511 and is available through the Texas SmartBuy portal, with a response deadline of August 7, 2026. The services are expected to support patient care within the behavioral health system in Texas, though the exact performance location is not specified. This opportunity is open to qualified providers who can ensure accurate, timely, and compliant lab testing aligned with clinical standards for this population.

POSTED

DEADLINE

Comprehensive Clinical Laboratory Testing and On-Site Specimen Collection ServicesIntegral Care is soliciting proposals for comprehensive clinical laboratory testing and on-site specimen collection services to support individuals receiving behavioral health and community-based care in Texas. The selected provider will deliver a wide range of diagnostic laboratory services including blood panels, hematology, endocrine testing, urinalysis, toxicology and drug screening, therapeutic drug monitoring, infectious disease testing, STI and HIV screening, tuberculosis testing, and other medically necessary diagnostics. The provider must demonstrate the ability to handle high-volume testing demands with reliable turnaround times for routine and expedited services such as CBC, A1C, lipid panels, comprehensive metabolic panels, thyroid testing, and urine toxicology. STAT and rapid testing options with clearly defined timelines are required to support crisis stabilization, medication management, and clinical decision-making. Proposals must detail operational capacity, staffing, equipment, and logistical capabilities to ensure consistent, high-quality service delivery across multiple community-based locations. All questions must be submitted by Monday, July 27, 2026, and proposals are due no later than Friday, August 7, 2026, at 5:00 p.m. Central Daylight Time. The solicitation is managed by Integral Care in Austin, Texas, with primary contacts listed for inquiries and correspondence.

POSTED

DEADLINE

After-Hours and Reasonable Suspicion TestingThe contract requires a vendor to provide on-demand drug and alcohol testing services during non-business hours to address safety incidents or observed signs of impairment, with a strict mandate for 24/7 availability and rapid response capabilities. Testing must be conducted promptly following an incident or suspicion of impairment, and all results must be delivered on the same day to ensure timely decision-making and regulatory compliance. The service must support a safety-sensitive environment where immediate intervention is critical, and the vendor is expected to maintain high operational readiness without disruption. This subcontract, classified under NAICS code 621511 for medical and diagnostic laboratories, is issued by the Florida Finance agency and is open for responses until August 14, 2026. The place of performance and specific location details are not specified, indicating flexibility in service delivery across the state. The vendor must demonstrate proven experience in emergency testing protocols, secure chain-of-custody procedures, and the ability to integrate seamlessly into existing safety and compliance frameworks. There is no set-aside specification, meaning the opportunity is open to all qualified entities regardless of business size or ownership structure.

POSTED

DEADLINE

Follow-Up Drug TestingThe contract requires the provision of scheduled follow-up drug testing for employees subject to post-violation monitoring, ensuring compliance through unannounced testing at predetermined intervals to maintain integrity and deterrence. Testing must be conducted reliably and consistently, with strict protocols in place to ensure chain of custody and result accuracy. Long-term data retention is a critical component, as all test records must be securely stored for extended periods to support future audits, regulatory reviews, and compliance verification. The scope is limited to services under a subcontract, tied to the NAICS code 621511 for medical laboratories, and is administered by the Florida Finance agency with a response deadline of August 14, 2026. There is no specified place of performance or point of contact, indicating the service may be delivered remotely or across multiple locations within the state.

POSTED

DEADLINE

Fitness-for-Duty / Return-to-Work TestingThe contract pertains to conducting drug and alcohol testing for employees returning to work after medical leave, rehabilitation, or injury, ensuring compliance with City occupational health protocols and reporting standards. The testing program must be fully integrated with existing municipal health and safety procedures to support safe and responsible workforce reintegration. It is classified as a subcontract under NAICS code 621511, indicative of medical and diagnostic laboratories, and is issued by the Finance agency of Florida. The opportunity was posted on July 17, 2026, with a response deadline of August 14, 2026. While specific performance location details are not provided, the work is expected to align with City-wide operational requirements. All submissions must be made through the designated online portal prior to the deadline.

POSTED

DEADLINE

Random Drug Testing ServicesThe contract requires the provision of random drug testing services for City employees, encompassing full-cycle support including on-site specimen collection, strict chain-of-custody documentation, laboratory analysis, and accurate reporting in full alignment with federal and state regulatory standards. Compliance with Department of Transportation, Nuclear Regulatory Commission, and Florida Statutes is mandatory, ensuring all procedures meet the highest legal and operational benchmarks for workplace safety and regulatory accountability. Services must be delivered on a scheduled, unpredictable basis to maintain the integrity of the testing program, with all data handled securely and reported in a timely manner to authorized personnel. The contract is structured as a subcontract under the Finance department of the State of Florida, with a North American Industry Classification System code of 621511, indicating focus on medical and diagnostic laboratories. The solicitation is open for responses until August 14, 2026, and performance is expected to occur within the jurisdictional boundaries governed by Florida law, though specific location details for the place of performance are not defined in the available data.

POSTED

DEADLINE

Q301--Microbiological TestingThe Department of Veterans Affairs, through Network Contract Office 23, intends to award a sole source, firm-fixed price contract to Monument Health Rapid City Hospital, Inc. for microbiological testing services under the authority of 41 U.S.C. 3304(a)(1) and FAR 12.201-1, as it is the only vendor in the geographic area capable of meeting the specialized requirements outlined in the statement of work. Monument Health is uniquely positioned due to its certifications, facilities, and consistent ability to deliver testing within critical timelines, making it the sole provider eligible for this requirement. The North American Industry Classification System code is 621511 and the product/service code is Q301, with performance to occur in Fort Meade, South Dakota, while the contracting office is located in Saint Paul, Minnesota. Although this notice is not a solicitation, interested vendors may submit capability statements to demonstrate their ability to fulfill the requirements, which will inform the government’s decision on whether to proceed with a competitive procurement. Submissions must include the organization’s name, UEI, contact information, detailed capability statement covering methods of collection, shipping timelines, and testing guarantees, along with any authorization agreements with manufacturers. Small businesses must specify estimated prime and subcontracted percentages, and all responders must indicate if services or supplies can be sourced through existing government contracts. Responses must be sent to cameron.rick@va.gov no later than July 22, 2026, and the government retains full discretion to determine competition based on submitted information.

Network Contract Office 23 (36C263)

POSTED

DEADLINE

Q301--Intent to Sole Source Specialized laboratory medical testing servicesThe Department of Veterans Affairs, through Network Contract Office 21, intends to award a sole source firm fixed price contract to Mayo Collaborative Services, Inc. for specialized laboratory medical testing services, with a base year and up to four additional option years, based on the determination that Mayo is the only authorized provider capable of performing the required tests. These services include highly specialized assays such as neuromyelitis optica/Aquaporin-4 FACS IgG titer, myelin oligodendrocyte glycoprotein FACS titer, glutamic acid decarboxylase antibody testing in spinal fluid, and several other neural and paraneoplastic antibody analyses performed on serum and body fluids. The contracting office asserts that no other entity is authorized or capable of delivering these exact testing methodologies, justifying the sole source approach under NAICS code 621511 with a size standard of $41.5 million. Interested parties may respond if they believe they can meet the requirements outlined in the attached Statement of Work, but must submit both their capabilities and an explicit authorization letter from Mayo Collaborative Services, Inc. to angela.gerlitzki1@va.gov no later than July 24, 2026, at 10 a.m. PST. This notice is not a solicitation for competition and the government retains full discretion to proceed without a competitive process regardless of responses received.

261-NETWORK Contract Office 21 (36C261)

POSTED

DEADLINE

Thyroseq V3 molecular testing for fine needle aspiration biopsy samples of thyroid nodulesThe contract pertains to Thyroseq V3 molecular testing for fine needle aspiration biopsy samples of thyroid nodules, aiming to support diagnostic precision through advanced genomic analysis. It is issued under solicitation number 75N98026Q00822 by the National Institutes of Health Olao, a component of the Department of Health and Human Services, with the NAICS code 621511 indicating alignment with medical laboratories and diagnostic services. The solicitation was posted on July 17, 2026, with a response deadline of July 27, 2026, and performance is expected to occur in Bethesda, Maryland, where the office is located at 20892. James B. Law serves as the primary point of contact, reachable via email at james.law@nih.gov, and all submissions must be made through the SAM.gov portal referenced in the provided link. The contract does not specify any set-aside provisions, indicating it is open to all eligible offers without preference or restriction.

National Institutes Of Health Olao

POSTED

DEADLINE

Specialized Toxicology Testing (Optional)The contract involves optional specialized toxicology testing for heavy metals including mercury, cadmium, and chromium, to be conducted in accordance with ACGIH Biological Exposure Index guidelines. Testing must be pre-approved and accompanied by full chain of custody documentation to ensure sample integrity and regulatory compliance. The work is structured as a subcontract under the California Department of Toxic Substances Control, with performance located in Alameda. The solicitation was posted on July 16, 2026, and responses are due no later than August 5, 2026. The NAICS code 621511 indicates this falls under medical and diagnostic laboratories, reflecting the technical nature of the testing services required. While not mandatory, participation requires strict adherence to protocol, documentation standards, and timing constraints to meet state regulatory expectations.

California Department Toxic Substances Control

POSTED

DEADLINE